Acura Pharmaceuticals Inc (ACUR)
0.01
0.00 (0.00%)
USD |
OTCM |
Apr 30, 16:00
Acura Pharmaceuticals Cash from Financing (Quarterly): -0.269M for Sept. 30, 2021
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2021 | 0.402M |
| September 30, 2021 | -0.269M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.261M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.269M |
| March 31, 2020 | 0.001M |
| December 31, 2019 | -0.275M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 1.261M |
| March 31, 2019 | 0.403M |
| December 31, 2018 | 1.296M |
| September 30, 2018 | 0.201M |
| June 30, 2018 | 0.763M |
| March 31, 2018 | -0.481M |
| December 31, 2017 | -0.945M |
| September 30, 2017 | 3.307M |
| June 30, 2017 | -0.677M |
| March 31, 2017 | -0.445M |
| December 31, 2016 | -0.868M |
| September 30, 2016 | -0.637M |
| June 30, 2016 | -0.625M |
| March 31, 2016 | -0.409M |
| December 31, 2015 | -0.80M |
| Date | Value |
|---|---|
| September 30, 2015 | 6.446M |
| June 30, 2015 | -0.356M |
| March 31, 2015 | 0.001M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -0.52M |
| December 31, 2013 | 9.769M |
| September 30, 2013 | 2.983M |
| June 30, 2013 | 0.251M |
| March 31, 2013 | -0.714M |
| December 31, 2012 | -0.002M |
| September 30, 2012 | 0.001M |
| June 30, 2012 | -0.005M |
| March 31, 2012 | -1.032M |
| December 31, 2011 | -0.009M |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.277M |
| March 31, 2011 | -0.809M |
| December 31, 2010 | 0.00 |
| September 30, 2010 | 0.00 |
| June 30, 2010 | 0.392M |
| March 31, 2010 | 0.00 |
| December 31, 2009 | 0.16M |
| September 30, 2009 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.275M
Minimum
Dec 2019
1.261M
Maximum
Jun 2019
0.15M
Average
--
Median
Sep 2019
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.026M |
| Palatin Technologies Inc | 4.974M |
| iBio Inc | 4.005M |
| Theriva Biologics Inc | -1.457M |
| Oragenics Inc | -0.1806M |